Differential gene expression in pituitary adenomas by oligonucleotide array analysis
Open Access
- 1 July 2005
- journal article
- Published by Oxford University Press (OUP) in Acta Endocrinologica
- Vol. 153 (1), 143-151
- https://doi.org/10.1530/eje.1.01937
Abstract
Objectives: Microarray technology allows for the expression profile of many thousands of genes to be quantified at the same time, and has resulted in novel discoveries about the tumour biology of a number of cancers. We sought to do this in pituitary adenomas, the most common intracranial neoplasm. Methods: Affymetrix GeneChip HG-U133A oligonucleotide arrays covering 14 500 well-characterised genes from the human genome were used to study pooled RNA for each of the four major pituitary adenoma subtypes. Individual gene-expression levels in the tumours were compared relative to the expression profile in normal pooled pituitary RNA. Three differentially expressed genes with potential importance in tumourigenesis were chosen for validation by real-time quantitative PCR on the original tumours and on an additional 26 adenomas. Results: Bioinformatic analysis showed that 3906 genes and 351 expressed sequence tags were differentially expressed among all pituitary tumour subtypes. Lysosomal-associated protein transmembrane- 4-β (LAPTM4B), a novel gene upregulated in hepatocellular carcinoma, was significantly over-expressed in adrenocorticotrophin (ACTH)-secreting adenomas and non-functioning pituitary adenomas (NFPAs). Bcl-2-associated athanogene (BAG1), an anti-apoptotic protein found at high levels in a number of human cancers, was significantly over-expressed in growth hormone-secreting and prolactin-secreting adenomas and NFPAs. The cyclin-dependent kinase inhibitor p18, in which murine gene deletion has been shown to produce pituitary ACTH cell hyperplasia and adenomas, was significantly under-expressed in ACTH-secreting adenomas. Conclusions: Expression array analysis of pituitary adenomas using the Affymetrix GeneChip HG-U133A arrays appears to be a valid method of identifying genes that may be important in tumour pathogenesis.Keywords
This publication has 17 references indexed in Scilit:
- Reexpression of p8 Contributes to Tumorigenic Properties of Pituitary Cells and Appears in a Subset of Prolactinomas in Transgenic Mice that Hypersecrete Luteinizing HormoneMolecular Endocrinology, 2004
- Identification of Adrenocorticotropin Receptor Messenger Ribonucleic Acid in the Human Pituitary and Its Loss of Expression in Pituitary AdenomasJournal of Clinical Endocrinology & Metabolism, 2003
- A Pituitary-Derived MEG3 Isoform Functions as a Growth Suppressor in Tumor CellsJournal of Clinical Endocrinology & Metabolism, 2003
- Involvement of bone morphogenetic protein 4 (BMP-4) in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalkProceedings of the National Academy of Sciences of the United States of America, 2003
- Loss of Expression of GADD45 , a Growth Inhibitory Gene, in Human Pituitary Adenomas: Implications for TumorigenesisJournal of Clinical Endocrinology & Metabolism, 2002
- Early Gene Expression Changes Preceding Thyroid Hormone-Induced Involution of a Thyrotrope TumorEndocrinology, 2002
- Novel Patterns of Gene Expression in Pituitary Adenomas Identified by Complementary Deoxyribonucleic Acid Microarrays and Quantitative Reverse Transcription-Polymerase Chain ReactionJournal of Clinical Endocrinology & Metabolism, 2001
- Differential Pituitary Gene Expression Profiles Associated- To Aging and Spontaneous Tumors as Revealed by cDNA Expression ArrayEndocrinology, 2000
- Isolation and Characterization of a Pituitary Tumor-Transforming Gene (PTTG)Molecular Endocrinology, 1997
- GTPase inhibiting mutations activate the α chain of Gs and stimulate adenylyl cyclase in human pituitary tumoursNature, 1989